脂质聚合物纳米粒的研究进展
作者：赵一擎;刘颖;冯年平;
Author：
收稿日期： 年卷（期）页码：2014,29(05):-602-605
期刊名称：华西药学杂志
Journal Name：WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字：脂质聚合物纳米粒;药物递送系统;制备;脂质囊泡
Key words：
基金项目：国家自然科学基金资助项目(批准号:81303232);;
上海市科委自然科学基金项目(编号:11ZR1436500)
中文摘要
从制备方法及应用角度对脂质聚合物纳米粒的研究进展进行综述,脂质聚合物纳米粒在递送药物、基因及诊断成像剂等方面具有较好的发展前景。
参考文献
[1]Rogueda PG,Traini D.The nanoscale in pulmonary delivery.Part1:Deposition,fate,toxicology and effects[J].Expert Opin Drug Deliv,2007,4(6):595-606.
[2]Pinto-Alphandary H,Andremont A,Couvreur P.Targeted delivery of antibiotics using liposomes and nanoparticles:Research and applications[J].Int J Antimicrob Ag,2000,13(3):155-168.
[3]Cheow WS,Hadinoto K.Enhancing encapsulation efficiency of highly watersoluble antibiotic in poly (lactic-co-glycolic acid)nanoparticles:Modifications of standard nanoparticle preparation methods[J].Colloids Surf A,2010,370:79-86.
[4]Yang XZ,Dou S,Wang YC,et al.Single-step assembly of cationic lipid polymer hybrid nanoparticles for systemic delivery of siRNA[J].ACS Nano,2012,6(6):4955-4965.
[5]Gref R,Minamitake Y,Peracchia MT,et al.Biodegradable longcirculating polymeric nanospheres[J].Sci,1994,263(5153):1600-1603.
[6]Yoncheva K,Gomez S,Campanero MA,et al.Bioadhesive properties of pegylated nanopartieles[J].Expert Opin Drug Deliv,2005,2(2):205-218.
[7]Zheng Y,Yu B,Weecharangsan W,et al.Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7α-APTADD to breast cancer cells[J].Int J Pharm,2010,390(2):234-241.
[8]Liu YT,Li K,Pan J,et al.Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel[J].Biomaterials,2010,31(2):330-338.
[9]Liu YT,Pan J,Feng SS.Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel:Effects of surfactants on particles size,characteristics andin vitro performance[J].Int J Pharm,2010,395(1-2):243-250.
[10]Cheow WS,Hadinoto K.Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles[J].Colloids Surf B:Biointerfaces,2011,85(2):214-220.
[11]Wang T,Deng Y,Geng T,et al.Preparation of submicron unilamellar liposomes by freeze-drying double emulsions[J].Biochim Biophys Acta,2006,1758(2):222-231.
[12]Beija M,Salvayre R,Lauth-De VN,et al.Colloidal systems for drug delivery:From design to therapy[J].Trends Biotechnol,2012,30(9):485-496.
[13]Hatziantonioy S,Demetzos C.Lipids of membranes:Chemistry,biological role and applications as drug carriers[J].Stud Nat Prod Chem,2008,34:173-202.
[14]Li Y,Wong HL,Shuhendler AJ,et al.Molecular interactions,internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles[J].J Control Rel,2008,128(1):60-70.
[15]Hitzman CJ,Elmquist WF,Wiedmann TS.Development of a respirable,sustained release microcarrier for 5-fluorouracil II:In vitro and in vivo optimization of lipid coated nanoparticles[J].J Pharm Sci,2006,95(5):1127-1143.
[16]Hitzman CJ,Wattenberg LW,Wiedmann TS.Pharmacokinetics of5-fluorouracil in the hamster following inhalation delivery of lipid-coatednanoparticles[J].J Pharm Sci,2006,95(6):1196-1211.
[17]Sengupta S,Eavarone D,Capila I,et al.Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system[J].Nature,2005,436(7050):568-572.
[18]Wang A,Yuet K,Zhang L,et al.ChemoRad nanoparticles:A novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation[J].Nanomedicine,2010,5(3):361-368.
[19]Li B,Xu H,Li Z,et al.Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies[J].Int J Nanomed,2012,7:187-197.
[20]Bathfield M,Daviot D,D'Agosto F,et al.Synthesis of lipid-α-end-functionalized chains by RAFT polymerization.Stabilization of lipid/polymer particle assemblies[J].Macromolecules,2008,41:8346-8353.
[21]Troutier A,Delair T,Pichot C,et al.Physicochemical and interfacial investigation of lipid/polymer particle assemblies[J].Langmuir,2005,21(4):1305-1313.
[22]Troutier AL,Ladaviere C.An overview of lipid membrane supported by colloidal particles[J].Adv Colloid Interface Sci,2007,133(4):1-21.
[23]Heiati H,Phillips NC,Tawashi R.Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride[J].Pharm Res,1996,13(9):1406-1410.
[24]Tardieu A,Luzzati V,Reman FC.Structure and polymorphism of the hydrocarbon chains of lipids:A study of lecithin-water phases[J].J Mol Biol,1973,75(4):711-718.
[25]Gurny R,Peppas N,Harrington D,et al.Development of biodegradable and injectable latices for controlled release of potent drugs[J].Drug Dev Ind Pharm,1981,7(1):1-25.
[26]Valencia P,Basto P,Zhang L,et al.Single-step assembly of homogenous lipid-polymeric and lipidquantum dot nanoparticles enabled by microfluidic rapid mixing[J].ACS Nano,2010,4(3):1671-1679.
[27]Chan JM,Zhang L,Yuet KP,et al.PLGA-lecithin-PEG coreshell nanoparticles for controlled drug delivery[J].Biomaterials,2009,30(8):1627-1634.
[28]Hitzman CJ,Elmquist WF,Wattenberg LW,et al.Development of a respirable,sustained release microcarrier for 5-fluorouracil I:In vitro assessment of liposomes,microspheres,and lipid coated nanoparticles[J].J Pharm Sci,2006,95(5):1114-1126.
[29]Salvador-Morales C,Zhang LF,Langer R,et al.Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups[J].Biomaterials,2009,30:2231-2240.
[30]Chu CH,Wan YC,Huang HY,et al.Ultrafine PEG-coated poly(lactic-co-glycolic acid)nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications[J].Nanotechnology,2011,22(18):185601.
[31]Cheow WS,Chang MW,Hadinoto K.The roles of lipid in antibiofilm efficacy of lipid-polymer hybrid nanoparticles encapsulating antibiotics[J].Colloids Surf A,2011,389:158-165.
[32]Cheow WS,Hadinoto K.Lipid-polymer hybrid nanoparticles with rhamnolipid-triggered release capabilities as anti-biofilm drug delivery vehicles[J].Particuology,2012,10:327-333.
[33]Wang Y,Kho K,Cheow WS,et al.A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles[J].Int J Pharm,2012,424(1-2):98-106.
[34]Sengupta S,Eavarone D,Capila I,et al.Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system[J].Nature,2005,436(7050):568-572.
[35]Ebos JM,Lee CR,Kerbel RS.Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy[J].Clin Cancer Res,2009,15(16):5020-5025.
[36]Hu CM,Kaushal S,Tran Cao HS,et al.Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells[J].Mol Pharmaceutics,2010,7(3):914-920.
[37]Al-Dosair MS,Gao X.Nonviral Gene Delivery:Principle,limitations,and recent progress[J].AAPS J,2009,11(4):671-681.
[38]Li J,He YZ,Li W,et al.A novel polymer-lipid hybrid nanoparticle for efficient nonviral gene delivery[J].Acta Pharmacol Sin,2010,31(4):509-514.
[39]Mieszawska AJ,Gianalla A,Cormode DP,et al.Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging[J].Chem Commun,2012,48(47):5835-5837.
【关闭】
